OGDEN, Utah--(BUSINESS WIRE)--Setpoint Systems (http://www.setpointusa.com), a leader in design and manufacture of custom lean automation solutions and manufacturing ...

SetPoint System® is first-of-its-kind neuroimmune modulation device for the treatment of adults living with moderate-to-severe rheumatoid arthritis VALENCIA, Calif., November 24, 2025--(BUSINESS WIRE) ...

The U.S. Food and Drug Administration has approved the SetPoint System, a neuroimmune modulation device for the treatment of adults living with moderate-to-severe rheumatoid arthritis (RA). The ...

Treatment follows recent Food and Drug Administration approval of the SetPoint System for treatment of RA, a bioelectronic medicine breakthrough Northwell is first to implant patient with FDA-approved ...

Four presentations highlight 12-month clinical outcomes, as well as MRI-assessed joint protection and patient perspectives supporting the SetPoint System as first-of-its-kind treatment for rheumatoid ...

SetPoint Medical has submitted a premarket approval (PMA) application to the US Food and Drug Administration (FDA) for a neuroimmune modulation device aimed at treating rheumatoid arthritis (RA) ...

Credit: SetPoint Medical. The SetPoint System is a rechargeable neurostimulation device that is implanted on the vagus nerve. Treatment with the SetPoint System, a neuroimmune modulation device, was ...

SetPoint Medical has raised $140 million. This includes $25 million in the second tranche of its Series C financing, as well as $115 million in its Series D financing, co-led by Elevage Medical ...

NEW HYDE PARK, N.Y. & VALENCIA, Calif.--(BUSINESS WIRE)--Northwell Health and SetPoint Medical today announced that Northwell is the first health system to provide the recent U.S. Food and Drug ...

SetPoint Medical to Present Data at ACR Convergence 2025 Demonstrating Sustained Efficacy and Safety for the SetPoint System to Treat Rheumatoid Arthritis Four presentations highlight 12-month ...